BRIEF-Adaptimmune Q1 revenue $2.9 million versus $2.7 million

* Adaptimmune therapeutics plc qtrly loss per share $0.04 per ordinary share
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.